Home
    • Plans Blog Contact
    Procept Biorobotics Corp logo

    Procept Biorobotics Corp

    PRCT
    Last price US$21.65
    Market cap US$1.2b
    12M price change -46.04%
    Loading the 12-month Mave Thesis and 1-month news signal

    Industry and sector peers, plus broader research alternatives

    View comparison
    AmerisourceBergenABC Industry peer Insulet CorporationPODD Industry peer NuVasive IncNUVA Industry peer Zoetis IncZTS Sector peer
    Overview Earnings Report Price History News Competitors Earnings per Share Return on Equity Net Margin Share Buyback Leverage Financial Statements Financial Ratio
    Dashboard Funda..tals Prediction Screener Map

    Procept Biorobotics Corp Overview

    Industry: Healthcare Equipment & Supplies

    Sector: Healthcare

    PROCEPT BioRobotics Corporation, a surgical robotics company, develops transformative solutions in urology. It develops, manufactures, and sells AquaBeam Robotic System, an image-guided, surgical robotic system for use in minimally invasive urologic surgery with a focus on treating benign prostatic hyperplasia (BPH). The company also designs Aquablation therapy for males suffering from lower urinary tract symptoms due to BPH. PROCEPT BioRobotics Corporation was incorporated in 2007 and is headquartered in Redwood City, California. PROCEPT BioRobotics Corporation, a surgical robotics company, develops transformative solutions in urology. It develops, manufactures, and sells AquaBeam Robotic System, an image-guided, surgical robotic system for use in minimally invasive urologic surgery with a focus on treating benign prostatic Read More

    Mavefund brings filings, fundamentals, valuation, price history and news for Procept Biorobotics Corp into one research view. The sections below show what strengthens or weakens the research case.

    Score

    Reported Results

    What the company reported, with filing details kept small.

    Filed Aug 04, 2026

    Quarterly result summary

    Revenue was $94.5M (reported). Net loss was -$26.9M. Adjusted EBITDA was -$11.3M (+42% YoY).

    Revenue $94.5M reported
    Net loss -$26.9M reported
    Adjusted EBITDA -$11.3M +42% YoY

    What changed

    • Revenue reported to $94.5M.
    • Adjusted EBITDA +42% YoY to -$11.3M.

    Guidance / outlook

    No formal outlook was extracted from this filing excerpt. Open the SEC source to review full management commentary.

    Earnings release Open filing

    Source: SEC EDGAR company-filed earnings materials. Dates are shown only for verification; review the source filing before relying on extracted report details.

    Other recent earnings materials
    SEC filing 10-Q Aug 05, 2026 SEC filing 8-K Aug 04, 2026 SEC filing 10-Q Apr 30, 2026 SEC filing 8-K Apr 29, 2026 Earnings release Earnings release Apr 29, 2026 SEC filing 10-K Feb 26, 2026 SEC filing 8-K Feb 25, 2026 Earnings release Earnings release Feb 25, 2026 SEC filing 10-Q Nov 05, 2025 Earnings release Earnings release Nov 04, 2025 SEC filing 8-K Nov 04, 2025

    Prediction-grade evidence

    Recent News

    Company-relevant articles from sources that pass the Mave Signal relevance and reliability checks.

    Earnings Per Share

    Score 3.00/5
    Procept Biorobotics Corp boasts a high score, as its Earnings Per Share (EPS) has demonstrated consistent growth over the past six years. Notable counterparts in the sector with high scores includes Zoetis Inc IQVIA Holdings Inc Agilent Technologies Inc
    In Healthcare Equipment & Supplies industry , AmerisourceBergen , Insulet Corporation , NuVasive Inc are companies with high ratings.

    Return on Equity

    Score 1.54/5
    Procept Biorobotics Corp exhibits a lower score in the Return on Equity (ROE) section, falling below the sector median value and indicating a comparatively weaker performance in this metric. The top companies in the same sector include Zoetis Inc IQVIA Holdings Inc Agilent Technologies Inc
    Procept Bior... PRCT US$1.2b
    Zoetis Inc ZTS US$31.9b
    IQVIA Holdin... IQV US$34.8b
    Agilent Tech... A US$37.9b

    Net Margin

    Score 1.48/5
    Procept Biorobotics Corp olds a low score as its net margin consistently trails below the sector median value and doesn't exhibit continuous growth over the last six years; notable companies in the sector with commendable scores include Zoetis Inc IQVIA Holdings Inc Agilent Technologies Inc
    Procept Bior... PRCT US$1.2b
    Zoetis Inc ZTS US$31.9b
    IQVIA Holdin... IQV US$34.8b
    Agilent Tech... A US$37.9b

    Share Buyback

    In Healthcare Equipment & Supplies industry , AmerisourceBergen , Insulet Corporation , NuVasive Inc are companies with high ratings.

    Leverage

    Score 2.73/5
    Procept Biorobotics Corp attains a commendable score in the category due to its lower leverage ratio over the past six years in comparison to the sector median value. Additionally, other notable companies in the same sector, such as Zoetis Inc IQVIA Holdings Inc Agilent Technologies Inc , also exhibit high scores.
    Procept Bior... PRCT US$1.2b
    Zoetis Inc ZTS US$31.9b
    IQVIA Holdin... IQV US$34.8b
    Agilent Tech... A US$37.9b

    Financial Statements

    Company-reported SEC EDGAR facts organized into the three core statements.

    Reported currency
    Verified SEC statements load when this section enters view.

    Source: SEC EDGAR companyfacts. Values are standardized company filings for research support, not personalized financial advice.

    Financial Ratio

    Yearly Quarterly

    Financial
    Profitability
    Growth
    Cash Flow
    Financial Health
    Efficiency Ratios

    Procept Biorobotics Corp logo

    Procept Biorobotics Corp

    US$21.65

    US$1.2b

    5.51%

    -46.04%